common.study.topics.clinical

Safety Evaluation of β-Arbutin in Healthy Human Subjects

common.study.values.description

“Safety Evaluation of β-arbutin in Healthy Human Subjects”

The purpose of this study is to determine the safety of synthetic beta-arbutin, a dietary supplement that aids in the prevention and treatment of calcium oxalate kidney stones, when administered to healthy human subjects.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Dietary Supplement - Beta-arbutin

Beta-arbutin capsules

Placebo

Placebo capsules containing non-medicinal ingredients

participant.views.study.view.additional

participant.views.study.view.scientific-title

Safety Evaluation of β-arbutin in Healthy Human Subjects

common.study.values.clinical-trial-id

NCT03868748

participant.views.study.view.id

epYnma